A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiving Chemotherapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorState University of New York at Buffalo

About this trial

Caloric restriction may alter the response to chemotherapy induced stress response and enhance its antitumor effect. This study intends to use an intermitted caloric restriction protocol with alternate days before the chemotherapy administration to enhance the cytotoxic effect generated by standard treatment of cancer.

Eligibility criteria

Qualifiers

• Histologically documented, cancer patients who are eligible to receive cytotoxic chemotherapy.

Life expectancy of at least 6 months

Adults ≥ 18 years of age

White blood cell (WBC) ≥ 2,500 cells/μL

Disqualifiers

• Eastern Cooperative Oncology Group (ECOG) performance status 2 or higher

Systemic corticosteroids; however, use of inhaled, intranasal, and topical steroids is acceptable.

High dose calcitriol [1,25(OH)2VitD] (i.e., > 7.0 μg/week)

Any infection requiring parenteral antibiotic therapy or causing fever (temperature > 100.5°F or 38.1°C) within 1 week prior to registration

Trial design

Treatments tested in this trial

  • Diet

Treatment groups

No treatment groups listed